Table 2.
In-silico analysis of the five overlapping peptides co-existing in both RP-HPLC and SCX fractions.
| No | Co-Existing Peptides in RP-HPLC and SCX Fractionation | Length | BIOPEP | ToxinPred | ||
|---|---|---|---|---|---|---|
| a A | b B | |||||
| 1 | RP R7 and SCX S2 | VPGLAL | 6 | 0.83 | 0.0004 | Non-toxic |
| 2 | LPSW | 4 | 0.75 | 0.0001 | Non-toxic | |
| 3 | RP R13 and SCX S2 | LVGLPL | 6 | 1.17 | 0.0008 | Non-toxic |
| 4 | WLQL | 4 | 0.50 | 0.0057 | Non-toxic | |
| 5 | LPLF | 4 | 0.75 | 0.0011 | Non-toxic | |
a A: The frequency of bioactive fragment occurrence in a protein sequence, b B: Potential biological activity of protein.